CNS & Neurological Disorders - Drug Targets

(Formerly Current Drug Targets - CNS & Neurological Disorders)


Cesar V. Borlongan
Department of Neurosurgery and Brain Repair
University of South Florida Morsani College of Medicine
Tampa, FL


Become EABM
Become Reviewer

Abstract Ahead of Print

Prion peptide 106-126 degradation potential of Serratiopetidase and Lumbrokinase - an in vitro and in silico perspective

Sanjay Kisan Metkar, Suparna Ghosh, Agnishwar Girigoswami and Koyeli Girigoswami*

Gut Microbiome: Lactation, Childbirth, Lung Dysbiosis, Animal Modeling, Stem Cell Treatment, and CNS disorders

Sydney Corey, Lauren Kvederis, Chase Kingsbury, Brooke Bonsack, Paul R. Sanberg, Vanessa Castelli, Jea-Young Lee and Cesar V. Borlongan*

Cannabidiol partially blocks the sleepiness in hypocretin-deficient rats. Preliminary data.

Eric Murillo-Rodríguez*, Diana Millán-Aldaco, Marcela Palomero-Rivero, Daniela Morales-Lara, Raphael Mechoulam and René Drucker-Colín